Vasculitis & polymyalgia rheumatica
Juvenile Behçet’s disease 2014–2024: multicenter study in Colombia
Authors' conclusion
Juvenile Behçet's disease in Colombia presents heterogeneous clinical presentations, with a high prevalence of mucocutaneous, musculoskeletal, and neurological involvement. A significant delay in diagnosis was observed
Study context
- Population
- Patients under 18 years meeting international diagnostic criteria for juvenile BD, 2014–2024, three Colombian cities (Cali, Bogotá, Pereira)60% female
- Participants
- 15 participants
- Outcome
- Clinical characteristics of juvenile BD
Methodological detailsdescriptive
- Descriptive
Main finding
As reported in the abstract
- Mean age at symptom onset (years)
- 6.1
- Mean age at diagnosis (years)
- 11.8
- Diagnostic delay (years)
- 5.7
- Recurrent oral aphthosis
- 100%
- Genital ulcers
- 73.3%
- Arthralgia
- 60%
- Neurological involvement
- 40%
- Vascular involvement (mainly venous thrombosis)
- 20%
- Positive pathergy test
- 44.4%
- Viral antigens detected
- 46.7%
Observational data: associations, not effects.
Further findings
Treatment
- Additional immunosuppressive therapy required
- 86.7%
- Patients treated with biologics
- 2
- Colchicine and GC received by all patients
Original publication
Juvenile Behçet’s disease 2014–2024: multicenter study in Colombia. Pediatr Rheumatol Online J. Published 28 January 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →